Landscapes / Targets
TYK2
7 drugs act on TYK2, in 48 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs7
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Janus kinase inhibitor |
Bristol Myers Squibb · Public BMY |
Approved | 18 Nov 2026soonPhase 3 trial completes | ||
| How it works | Blocks JAK enzymes that pass on immune signals | ||||
| Next date | 18 Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Plaque Psoriasis, Psoriatic Arthritis and 9 more | ||||
| Open drug page | |||||
Tyrosine kinase inhibitor |
Approved | 11 Dec 2026soonPhase 2 trial completes | |||
| How it works | Blocks a kinase | ||||
| Next date | 11 Dec 2026 · Phase 2 trial completes | ||||
| Also tested for | Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis and 2 more | ||||
| Open drug page | |||||
Janus kinase inhibitor |
Priovant Therapeutics +1 · Public PFE |
Approved | 31 Dec 2028Phase 2/3 trial completes | ||
| How it works | Blocks JAK enzymes that pass on immune signals | ||||
| Next date | 31 Dec 2028 · Phase 2/3 trial completes | ||||
| Also tested for | Cutaneous Sarcoidosis, Lichen Planopilaris | ||||
| Open drug page | |||||
Janus kinase inhibitor |
Phase 3 | 5 Feb 2027Phase 2 trial completes | |||
| How it works | Blocks JAK enzymes that pass on immune signals | ||||
| Next date | 5 Feb 2027 · Phase 2 trial completes | ||||
| Also tested for | Psoriatic Arthritis, Crohn's Disease and 5 more | ||||
| Open drug page | |||||
— |
Phase 3 | 12 Jul 2027Phase 3 trial completes | |||
| Next date | 12 Jul 2027 · Phase 3 trial completes | ||||
| Also tested for | Plaque Psoriasis, UC - Ulcerative Colitis and 9 more | ||||
| Open drug page | |||||
— |
Phase 3 | Aug 2027Phase 2 trial completes | |||
| Next date | Aug 2027 · Phase 2 trial completes | ||||
| Also tested for | Inflammatory Bowel Diseases, Psoriatic Arthritis and 2 more | ||||
| Open drug page | |||||
Pacritinibnot checked |
Kinase inhibitor |
Phase 2 | Jul 2028Phase 2 trial completes | ||
| How it works | Blocks a kinase | ||||
| Next date | Jul 2028 · Phase 2 trial completes | ||||
| Also tested for | Leukemia, Myelomonocytic, Chronic | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 6 of 7 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026